Nanobiotix Receives €14 Million Through the Second Tranche Disbursement of Financing from the European Investment Bank

Paris, France and Cambridge, Massachusetts (USA), Mar. 4 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the Company received €14 million through the second tranche disbursement of the non-dilutive loan from the European Investment Bank (EIB), which was originally [...]